The effectiveness of non-nucleoside dual therapy in “naive” HIV patients
INTRODUCTION: Non-nucleoside antiretroviral therapy (ART) regimens are used to reduce the risk of adverse events associated with the use of nucleoside reverse transcriptase inhibitors. One of these treatment regimens is dolutegravir, dovavirin (DTG, DOR) dual therapy. MATERIALS AND METHODS: The stud...
Saved in:
Main Authors: | Elena Veselova, Karina Kocharyan, Alla Peregudova, Valentina Tinkova, Anastasia Samoilova, Anastasiya Gaida |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-12-01
|
Series: | Journal of Global Antimicrobial Resistance |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213716524001875 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries
by: Davy-Hyacinthe Gouissi Anguechia, et al.
Published: (2024-11-01) -
Nucleoside analogues in treatment of liver cirrhosis as an outcome of chronic hepatitis B
by: I. G. Bakulin
Published: (2009-02-01) -
Spectrum of Non-Nucleoside Reverse Transcriptase Inhibitor-Associated Drug Resistance Mutations in Persons Living with HIV-1 Receiving Rilpivirine
by: Pavithra Nagarajan, et al.
Published: (2024-10-01) -
Bacteria-specific modified nucleoside is released and elevated in urine of patients with bacterial infections
by: Ryosuke Yamamura, et al.
Published: (2025-01-01) -
Production of Value-Added Arabinofuranosyl Nucleotide Analogues from Nucleoside by an In Vitro Enzymatic Synthetic Biosystem
by: Yuxue Liu, et al.
Published: (2024-11-01)